New drugs backed by CHMP include Zavicefta, Zinbryta

On Friday, EMA's CHMP recommended approval of several new drugs, including Zavicefta ceftazidime/avibactam ( CAZ-104), Zinbryta daclizumab, Odefsey rilpivirine/ emtricitabine/tenofovir alafenamide and Ongentys opicapone.

The committee

Read the full 263 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE